Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision changed from v3.8.0 to v3.8.1. The study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T03:27:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab plus epacadostat versus standard-of-care treatment in metastatic renal cell carcinoma is displayed, with study design, eligibility, outcomes, participating locations, and record documents. It indicates that the study is completed and no longer recruiting.
    Difference
    100%
    Check dated 2026-11-11T02:17:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-04T01:09:20.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A site-wide notice about NIH terminology updates was added, and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:06:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier advances from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T01:04:51.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the previous full content and navigation with a minimal header. Users can no longer view the study details and related links on this page.
    Difference
    17%
    Check dated 2026-09-23T01:12:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.